Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
eQbFpy9E7vtArXNv